Literature DB >> 24663219

Thyroid function. Pathogenesis of Graves ophthalmopathy--a role for TSH-R?

Jack R Wall1.   

Abstract

A new study highlights the complexities of anti-TSH-receptor antibody function and the differences between adult and paediatric patients with Graves disease, adding to the controversy regarding the possible role of these antibodies in the development of ophthalmopathy.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24663219     DOI： 10.1038/nrendo.2014.37

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  7 in total

1.  The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.

Authors:  W B Kim; H K Chung; Y J Park; D J Park; K Tahara; L D Kohn; B Y Cho
Journal:  Thyroid       Date:  2000-07       Impact factor: 6.568

2.  Association of TSH receptor antibody, thyroid stimulating antibody, and thyroid blocking antibody with clinical activity score and degree of severity of Graves ophthalmopathy.

Authors:  Imam Subekti; Asman Boedisantoso; Nila Djuwita Moeloek; Sarwono Waspadji; Muchtaruddin Mansyur
Journal:  Acta Med Indones       Date:  2012-04

3.  Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins.

Authors:  S D Lytton; Y Li; P D Olivo; L D Kohn; G J Kahaly
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

4.  Eye and eyelid abnormalities are common in patients with Hashimoto's thyroiditis.

Authors:  Hilman Tjiang; Hooshang Lahooti; Tom McCorquodale; Kishan R Parmar; Jack R Wall
Journal:  Thyroid       Date:  2010-03       Impact factor: 6.568

5.  A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.

Authors:  S D Lytton; K A Ponto; M Kanitz; N Matheis; L D Kohn; G J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  2010-03-17       Impact factor: 5.958

6.  Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study.

Authors:  T Diana; R S Brown; A Bossowski; M Segni; M Niedziela; J König; A Bossowska; K Ziora; A Hale; J Smith; S Pitz; M Kanitz; G J Kahaly
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

7.  Graves' ophthalmopathy in childhood and adolescence.

Authors:  S H Uretsky; J S Kennerdell; J P Gutai
Journal:  Arch Ophthalmol       Date:  1980-11
  7 in total
  2 in total

1.  Single nucleotide polymorphism 1623 A/G (rs180195) in the promoter of the Thyroglobulin gene is associated with autoimmune thyroid disease but not with thyroid ophthalmopathy.

Authors:  Hooshang Lahooti; Senarath Edirimanne; John P Walsh; Leigh Delbridge; Emily J Hibbert; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2017-07-25

Review 2.  Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review.

Authors:  Thayalini Shanmuganathan; Christian Girgis; Hooshang Lahooti; Bernard Champion; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2015-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.